good one Zum.. amazing how the MO chatter has subsided. Without a doubt in my mind, there have been calculated attacks since reduce it data was published. DS and or big Pharma the PPS has been suppressed .. if amrn does close to half a billion with limited label what happens to share price when every T2DM and anyone with trig's over 150 and a bit overweight globally are prescribed this drug? the market is supposedly forward thinking in amrn's case not so much. Is it the IP situation? but I don't think so.. amrn behaves like no other bio I've ever owned.. most get a head of themselves yet this one hasn't based on NNT or RRR that are extremely rare.. this would make for a good docu drama :)
News 
Market Data 
Discover 
